J&J Ends Work on Addex Epilepsy Drug Candidate ADX71149: Report

Seeking Alpha17:52 ET

$100 Invested In Amphenol 15 Years Ago Would Be Worth This Much Today

Amphenol (NYSE:APH) has outperformed the market over the past 15 years by 7.64% on an annualized basis producing an average annual return of 19.86%. Currently, Amphenol has a market capitalization

Benzinga15:00 ET

Merck Gets Legal Victory As Appeals Court Dismisses Shingles Vaccine Some 1,200 Lawsuits

Merck & Co Inc (NYSE:MRK) has reportedly secured a significant legal victory as the 3rd U.S. Circuit Court of Appeals upheld the dismissal of nearly 1,200 lawsuits concerning its Zostavax shingles

Benzinga14:55 ET

Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst

Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70.

Benzinga14:51 ET

BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations

Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by

Benzinga14:50 ET

Top 10 S&P 500 Stocks Down More Than 5% From Last Week

Seeking Alpha13:36 ET